Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024

Monoclonal antibodies (mAbs) and other biological agents are being increasingly approved in the last years with very different indications. Their highly heterogeneous immunosuppressive effects, mechanisms of action and pharmacokinetics require comprehensive individualized vaccination schedules. Vacc...

Celý popis

Podrobná bibliografie

Vydáno v:	Expert review of vaccines Ročník 23; číslo 1; s. 887 - 910
Hlavní autoři:	Rivera-Izquierdo, Mario, Morales-Portillo, Arturo, Guerrero-Fernández de Alba, Inmaculada, Fernández-Martínez, Nicolás Francisco, Schoenenberger-Arnaiz, Joan Antoni, Barranco-Quintana, José Luis, Valero-Ubierna, Carmen
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Taylor & Francis Group 31.12.2024
Témata:	Biologic therapy biologics immunosuppression mAbs nirsevimab vaccine vaccine biologics mabs immunosuppression vaccine schedule nirsevimab Biologic therapy
ISSN:	1476-0584, 1744-8395, 1744-8395
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!